Recombinant GM-CSF (Plonmarlimab Biosimilar) antibody

Catalog No. ABIN7581349

The Human Monoclonal anti-GM-CSF (Plonmarlimab Biosimilar) antibody has been validated for ELISA, FACS, BLI, Func and SPR. It is suitable to detect GM-CSF (Plonmarlimab Biosimilar) in samples from Human.

Quick Overview for Recombinant GM-CSF (Plonmarlimab Biosimilar) antibody (ABIN7581349)

Target: GM-CSF (Plonmarlimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This GM-CSF (Plonmarlimab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-GM-CSF (Plonmarlimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CSF2 / GM-CSF Reference Antibody (plonmarlimab)

Characteristics: Anti-CSF2 / GM-CSF Reference Antibody (plonmarlimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for GM-CSF (Plonmarlimab Biosimilar)

Target: GM-CSF (Plonmarlimab Biosimilar)

Alternative Name: CSF2 (Plonmarlimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P04141